Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1992-4-13
pubmed:abstractText
Anti-neural antibodies have been implicated to play a role in the pathogenesis of nerve damage in leprosy patients. To find the relationship between anti-neural antibodies and clinical findings, we attempted to detect antibodies against neurofilament-enriched proteins by ELISA in sera from leprosy patients. Of 289 sera from leprosy patients, 74 (25.6%) had significant anti-neural antibodies; in contrast, 1 (5.0%) of 20 tuberculosis patients and 11 (7.1%) of 154 controls were seroreactive to nerve antigen. When clinical types were considered, a significant level of anti-neural IgG antibodies was detectable in 53 (30.1%) of 176 sera from lepromatous patients compared with 21 (18.6%) of 113 sera from tuberculoid patients, indicating that lepromatous patients were more likely to be seropositive to nerve antigens in ELISA. Some of the ELISA-reactive sera showed antibody reactivity with 38-kD, 40-kD and 43-kD nerve antigens in Western blotting analysis. There was no apparent correlation between seroreactivity to nerve antigens and bacterial load in leprosy patients. Although there was no statistical significance, anti-neural antibodies were detectable more often among the patients on chemotherapy than the untreated and among the patients with erythema nodosum leprosum than without. The results, therefore, suggest that anti-neural antibodies are elicited during the course of leprosy and may be associated with the extensiveness of nerve involvement in the patients.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-1186409, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-2319183, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-2463996, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-2545801, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-2674306, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-3511085, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-388439, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-5950347, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-6095579, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-6190769, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-6273673, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-6323330, http://linkedlifedata.com/resource/pubmed/commentcorrection/1544221-7028212
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
368-72
pubmed:dateRevised
2010-9-7
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
Detection of antibodies to human nerve antigens in sera from leprosy patients by ELISA.
pubmed:affiliation
Department of Microbiology, Yonsei University College of Medicine, Seoul, Korea.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't